Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basiliximab and Ruxolitinib for SR-aGVHD
NCT05021276Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Soochow University
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ruxolitinib, basiliximab in Acute Graft-Versus-Host Disease (aGvHD), sponsored by First Affiliated Hospital of Soochow University. Status: unknown.
02
Drugs
ruxolitinibbasiliximab
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT05021276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05021276.